Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
12.81 USD | +0.47% | -6.70% | -40.56% |
29/04 | Truist Securities Cuts Teladoc's Price Target to $15 From $17, Maintains Hold Rating | MT |
26/04 | UBS Adjusts Teladoc Price Target to $16 From $20, Maintains Neutral Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-40.56% | 2.17B | |
+40.56% | 2.69B | |
+24.41% | 536M | |
+42.77% | 467M | |
-64.35% | 157M | |
-39.57% | 74.88M |
- Stock Market
- Equities
- TDOC Stock
- News Teladoc Health, Inc.
- Credit Suisse Lowers Teladoc's PT to $151 from $207, Says Investors Concerned with Lack of Growth in Core Business, Maintains Outperform Rating